These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6318606)

  • 1. Opiate structure and activity--a guide to understanding the receptor.
    Thorpe DH
    Anesth Analg; 1984 Feb; 63(2):143-51. PubMed ID: 6318606
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structure-activity relationship of synthetic and semisynthetic opioid agonists and antagonists].
    Hosztafi S; Friedmann T; Furst Z
    Acta Pharm Hung; 1993 Nov; 63(6):335-49. PubMed ID: 8116454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical properties of opiate - cerebroside sulfate complex.
    Cho TM; Loh HH; Way EL
    Proc West Pharmacol Soc; 1975; 18():176-80. PubMed ID: 1178664
    [No Abstract]   [Full Text] [Related]  

  • 4. Narcotic binding to membrane acidic lipids.
    Loh HH; Cho TM; Cho JS; Way EL
    Prog Clin Biol Res; 1979; 27():27-49. PubMed ID: 218232
    [No Abstract]   [Full Text] [Related]  

  • 5. Peptide and nonpeptide ligands for opioid receptors.
    Misicka A
    Acta Pol Pharm; 1995; 52(5):349-63. PubMed ID: 8960271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.
    Watson B; Meng F; Akil H
    Neurobiol Dis; 1996 Feb; 3(1):87-96. PubMed ID: 9173916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity studies of narcotic agonists and antagonists from quantum chemical calculations.
    Loew GH; Berkowitz DS; Burt SK
    NIDA Res Monogr; 1978; (22):278-316. PubMed ID: 213725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
    Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereochemical anatomy of morphinomimetics.
    Janssen PA; Tollenaere JP
    Adv Biochem Psychopharmacol; 1979; 20():103-29. PubMed ID: 224656
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative stereo-structure-activity relationships I. Opiate receptor binding.
    Johnson H
    NIDA Res Monogr; 1978; (22):146-58. PubMed ID: 213724
    [No Abstract]   [Full Text] [Related]  

  • 11. An experimental and theoretical study of the morphine binding capacity and kinetics of an engineered opioid receptor.
    Kriz K; Debeljak N; Wärnmark I; Kriz D
    Biosens Bioelectron; 2007 Jan; 22(6):1168-71. PubMed ID: 17079129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantum chemical studies of molecular features and receptor interactions that modulate opiate agonist and antagonist activity.
    Burt SK; Loew GH; Hashimoto GM
    Ann N Y Acad Sci; 1981; 367():219-39. PubMed ID: 6266317
    [No Abstract]   [Full Text] [Related]  

  • 13. Perspectives in the chemistry of narcotic antagonists.
    Jacobson AE; May EL
    Adv Biochem Psychopharmacol; 1973; 8(0):187-9. PubMed ID: 4795005
    [No Abstract]   [Full Text] [Related]  

  • 14. Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains.
    Zhorov BS; Ananthanarayanan VS
    Arch Biochem Biophys; 2000 Mar; 375(1):31-49. PubMed ID: 10683246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proposed mode of action for narcotic agonists and antagonists.
    Cho TM; Law PY; Loh HH
    Adv Biochem Psychopharmacol; 1979; 20():69-101. PubMed ID: 224664
    [No Abstract]   [Full Text] [Related]  

  • 16. Stimulation of endothelial angiotensin-converting enzyme by morphine via non-opioid receptor mediated processes.
    Melzig MF; Heder G; Siems WE; Zipper J
    Pharmazie; 1998 Sep; 53(9):634-7. PubMed ID: 9770211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiocochemical, quantum chemical, and other theoretical techniques for the understanding of the pharmacologic action of drugs that affect the central nervous system: psychotropic drugs, narcotics, and narcotic antagonists and anesthetics.
    Kaufman JJ
    Cancer Chemother Rep 2; 1974 Dec; 4(4):49-50. PubMed ID: 4447934
    [No Abstract]   [Full Text] [Related]  

  • 18. [Morphine-like drugs and their antagonists in anesthesiology].
    Chauvin M; Viars P
    Ann Chir; 1986 Sep; 40(6):413-44. PubMed ID: 3592550
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of a new scaffold for opioid receptor antagonism based on the 2-amino-1,1-dimethyl-7-hydroxytetralin pharmacophore.
    Grundt P; Williams IA; Lewis JW; Husbands SM
    J Med Chem; 2004 Oct; 47(21):5069-75. PubMed ID: 15456250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Opioid peptides].
    Neuzil E; Cassaigne A
    Expos Annu Biochim Med; 1982; 35():161-214. PubMed ID: 6277687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.